Effect of Chronic Consumption of a Cranberry Beverage on Inflammation and Oxidative Stress
The Effect of Chronic Consumption of a Cranberry Beverage on Inflammation and Oxidative Stress in Healthy But Overweight/Obese Subjects: A Randomized Clinical Trial
1 other identifier
interventional
79
1 country
2
Brief Summary
The objective of this randomized, double-blind, placebo-controlled, parallel-design clinical trial is to investigate the potential antioxidant benefits of a cranberry beverage. The investigators hypothesize the chronic consumption of this beverage will improve indices of oxidative stress, inflammation, endothelial function, and glucoregulation. The investigators also hypothesize that these benefits will be particularly evident following an oral glucose tolerance test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2012
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2012
CompletedStudy Start
First participant enrolled
February 1, 2012
CompletedFirst Posted
Study publicly available on registry
February 7, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedJune 2, 2016
June 1, 2016
11 months
January 30, 2012
June 1, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Change in biomarkers of inflammation compared with placebo
Baseline and 8 weeks
Change in biomarkers of oxidative stress compared with placebo.
Baseline and 8 weeks
Study Arms (2)
Cranberry beverage
ACTIVE COMPARATORNon-cranberry beverage
PLACEBO COMPARATORInterventions
beverage containing cranberry at a dose of 15.2 ounces per day for 56 days.
Placebo Comparator - beverage absent cranberry at a dose of 15.2 ounces per day for 56 days.
Eligibility Criteria
You may qualify if:
- Men \& women, aged 30-70 years
- BMI 27-34.9 kg/m2
- waist:hip ratio \> 0.8 for women and \> 0.9 for men
You may not qualify if:
- Cigarette smoking and/or nicotine replacement use within last 6 months
- Individuals taking estrogen or testosterone
- Use of cholesterol-lowering medications
- Use of blood pressure-lowering medications
- Regular use (\> 1x/wk) of any stomach acid-lowering medications or laxatives (including fiber supplements)
- Cardiovascular (heart) disease
- Gastrointestinal disease
- Kidney disease
- Endocrine disease: including diabetes, untreated thyroid disease
- Rheumatoid arthritis
- Immune deficiency conditions
- Active treatment for any type of cancer, except basal cell carcinoma, within 1 year prior to study admission
- Systolic blood pressure \> 139 mmHg and/or diastolic blood pressure \> 89 mmHg
- Regular use of systemic steroids, oral or injectable
- Regular daily intake of ≥ 2 alcoholic drinks
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tufts Universitylead
- Washington State Universitycollaborator
- Ocean Spray, Inc.collaborator
Study Sites (2)
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts, 02111, United States
Washington State University
Pullman, Washington, 99164, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2012
First Posted
February 7, 2012
Study Start
February 1, 2012
Primary Completion
January 1, 2013
Study Completion
February 1, 2013
Last Updated
June 2, 2016
Record last verified: 2016-06